Structure

Physi-Chem Properties

Molecular Weight:  1208.61
Volume:  1205.461
LogP:  5.245
LogD:  3.693
LogS:  -4.975
# Rotatable Bonds:  20
TPSA:  264.51
# H-Bond Aceptor:  21
# H-Bond Donor:  5
# Rings:  10
# Heavy Atoms:  21

MedChem Properties

QED Drug-Likeness Score:  0.066
Synthetic Accessibility Score:  7.125
Fsp3:  0.723
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.428
MDCK Permeability:  0.0001324803160969168
Pgp-inhibitor:  0.131
Pgp-substrate:  0.999
Human Intestinal Absorption (HIA):  0.015
20% Bioavailability (F20%):  0.0
30% Bioavailability (F30%):  0.002

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.001
Plasma Protein Binding (PPB):  86.1124496459961%
Volume Distribution (VD):  0.16
Pgp-substrate:  6.731500625610352%

ADMET: Metabolism

CYP1A2-inhibitor:  0.0
CYP1A2-substrate:  0.949
CYP2C19-inhibitor:  0.009
CYP2C19-substrate:  0.347
CYP2C9-inhibitor:  0.2
CYP2C9-substrate:  0.002
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.049
CYP3A4-inhibitor:  0.744
CYP3A4-substrate:  0.921

ADMET: Excretion

Clearance (CL):  1.974
Half-life (T1/2):  0.076

ADMET: Toxicity

hERG Blockers:  0.901
Human Hepatotoxicity (H-HT):  0.211
Drug-inuced Liver Injury (DILI):  0.932
AMES Toxicity:  0.732
Rat Oral Acute Toxicity:  0.163
Maximum Recommended Daily Dose:  0.947
Skin Sensitization:  0.926
Carcinogencity:  0.242
Eye Corrosion:  0.003
Eye Irritation:  0.006
Respiratory Toxicity:  0.091

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475567

Natural Product ID:  NPC475567
Common Name*:   [(1S)-1-[(3S,8S,9R,10R,12R,13R,14R,17R)-3-[(2R,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4R,5R,6R)-5-[(2S,3R,4S,5S,6R)-3,5-Dihydroxy-4-Methoxy-6-Methyloxan-2-Yl]Oxy-4-Methoxy-6-Methyloxan-2-Yl]Oxy-4-Methoxy-6-Methyloxan-2-Yl]Oxy-4-Methoxy-6-Methyloxan-2-Yl]Oxy-8,14,17-Trihydroxy-10,13-Dimethyl-12-[(E)-3-Phenylprop-2-Enoyl]Oxy-1,2,3,4,7,9,11,12,15,16-Decahydrocyclopenta[A]Phenanthren-17-Yl]Ethyl] Benzoate
IUPAC Name:   [(1S)-1-[(3S,8S,9R,10R,12R,13R,14R,17R)-3-[(2R,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4R,5R,6R)-5-[(2S,3R,4S,5S,6R)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-8,14,17-trihydroxy-10,13-dimethyl-12-[(E)-3-phenylprop-2-enoyl]oxy-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate
Synonyms:  
Standard InCHIKey:  HPZZWLOXDVNZIY-KTZIEJBZSA-N
Standard InCHI:  InChI=1S/C65H92O21/c1-35-53(67)58(76-11)54(68)60(80-35)86-57-38(4)79-52(33-46(57)75-10)85-56-37(3)78-51(32-45(56)74-9)84-55-36(2)77-50(31-44(55)73-8)82-43-25-26-61(6)42(30-43)24-27-64(71)47(61)34-48(83-49(66)23-22-40-18-14-12-15-19-40)62(7)63(70,28-29-65(62,64)72)39(5)81-59(69)41-20-16-13-17-21-41/h12-24,35-39,43-48,50-58,60,67-68,70-72H,25-34H2,1-11H3/b23-22+/t35-,36-,37-,38-,39+,43+,44+,45+,46-,47-,48-,50+,51+,52+,53+,54-,55-,56-,57-,58+,60+,61+,62-,63+,64+,65-/m1/s1
SMILES:  CC1C(C(C(C(O1)OC2C(OC(CC2OC)OC3C(OC(CC3OC)OC4C(OC(CC4OC)OC5CCC6(C7CC(C8(C(CCC8(C7(CC=C6C5)O)O)(C(C)OC(=O)C9=CC=CC=C9)O)C)OC(=O)C=CC1=CC=CC=C1)C)C)C)C)O)OC)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL508391
PubChem CID:   44575256
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001013] Steroidal glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32487 leptadenia pyrotechnica Species Apocynaceae Eukaryota whole plant Dogon region, Mali 2002-Apr PMID[16643040]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1182 Cell Line J774.A1 Mus musculus IC50 = 1220.0 nM PMID[458269]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475567 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC473557
1.0 High Similarity NPC473468
0.9935 High Similarity NPC475531
0.9935 High Similarity NPC475175
0.9935 High Similarity NPC475198
0.9608 High Similarity NPC476784
0.9434 High Similarity NPC477488
0.9245 High Similarity NPC477491
0.9108 High Similarity NPC319404
0.9085 High Similarity NPC474564
0.9057 High Similarity NPC165234
0.9057 High Similarity NPC475536
0.9051 High Similarity NPC477623
0.9026 High Similarity NPC475447
0.9026 High Similarity NPC476092
0.9026 High Similarity NPC70236
0.9026 High Similarity NPC475218
0.9 High Similarity NPC473641
0.9 High Similarity NPC475505
0.9 High Similarity NPC475300
0.9 High Similarity NPC475464
0.9 High Similarity NPC475437
0.9 High Similarity NPC478125
0.9 High Similarity NPC473797
0.8938 High Similarity NPC478124
0.8924 High Similarity NPC318447
0.8924 High Similarity NPC322048
0.8903 High Similarity NPC476173
0.8861 High Similarity NPC323001
0.8861 High Similarity NPC326235
0.8854 High Similarity NPC472658
0.8854 High Similarity NPC472657
0.8841 High Similarity NPC477471
0.8841 High Similarity NPC477473
0.8841 High Similarity NPC477469
0.8841 High Similarity NPC477466
0.8812 High Similarity NPC326328
0.8812 High Similarity NPC471138
0.8812 High Similarity NPC309991
0.8812 High Similarity NPC323356
0.8797 High Similarity NPC469398
0.8797 High Similarity NPC469422
0.8797 High Similarity NPC34066
0.8782 High Similarity NPC469448
0.8766 High Similarity NPC29704
0.8766 High Similarity NPC174982
0.8766 High Similarity NPC472572
0.8766 High Similarity NPC472571
0.8766 High Similarity NPC470157
0.8766 High Similarity NPC472568
0.8766 High Similarity NPC200471
0.8766 High Similarity NPC177940
0.8766 High Similarity NPC476973
0.8766 High Similarity NPC184817
0.8766 High Similarity NPC473088
0.8766 High Similarity NPC96903
0.8766 High Similarity NPC472575
0.8766 High Similarity NPC469349
0.8766 High Similarity NPC158663
0.8766 High Similarity NPC470159
0.8766 High Similarity NPC171525
0.8766 High Similarity NPC471104
0.8766 High Similarity NPC70403
0.8734 High Similarity NPC471135
0.8718 High Similarity NPC471101
0.8718 High Similarity NPC266265
0.8718 High Similarity NPC92293
0.8718 High Similarity NPC301556
0.8718 High Similarity NPC270590
0.8701 High Similarity NPC476974
0.8701 High Similarity NPC163719
0.8701 High Similarity NPC472569
0.8701 High Similarity NPC472570
0.8701 High Similarity NPC475122
0.8701 High Similarity NPC25768
0.8701 High Similarity NPC475759
0.8701 High Similarity NPC57628
0.8701 High Similarity NPC470152
0.8701 High Similarity NPC11685
0.8701 High Similarity NPC241951
0.8701 High Similarity NPC95265
0.8701 High Similarity NPC70716
0.8701 High Similarity NPC125106
0.8701 High Similarity NPC472573
0.8701 High Similarity NPC95810
0.8701 High Similarity NPC188865
0.8698 High Similarity NPC475613
0.8679 High Similarity NPC469456
0.8654 High Similarity NPC281717
0.865 High Similarity NPC150893
0.865 High Similarity NPC329960
0.865 High Similarity NPC295408
0.8645 High Similarity NPC472556
0.8636 High Similarity NPC163087
0.8634 High Similarity NPC469399
0.8625 High Similarity NPC475638
0.8625 High Similarity NPC290683
0.8625 High Similarity NPC475548
0.8608 High Similarity NPC469415
0.8608 High Similarity NPC478123
0.8608 High Similarity NPC96308
0.8599 High Similarity NPC476975
0.859 High Similarity NPC473602
0.859 High Similarity NPC474935
0.8581 High Similarity NPC111466
0.8571 High Similarity NPC469421
0.8554 High Similarity NPC102465
0.8554 High Similarity NPC469420
0.8553 High Similarity NPC472548
0.8553 High Similarity NPC477905
0.8544 High Similarity NPC222102
0.8544 High Similarity NPC473214
0.8544 High Similarity NPC303429
0.8544 High Similarity NPC470245
0.8526 High Similarity NPC264270
0.8526 High Similarity NPC40085
0.8516 High Similarity NPC91703
0.8506 High Similarity NPC224491
0.8506 High Similarity NPC87448
0.8506 High Similarity NPC118080
0.8506 High Similarity NPC16912
0.8506 High Similarity NPC97947
0.8506 High Similarity NPC27377
0.8506 High Similarity NPC41481
0.8506 High Similarity NPC291599
0.8506 High Similarity NPC472576
0.8491 Intermediate Similarity NPC470153
0.8481 Intermediate Similarity NPC76103
0.8481 Intermediate Similarity NPC473215
0.8471 Intermediate Similarity NPC312393
0.8471 Intermediate Similarity NPC478263
0.8457 Intermediate Similarity NPC469417
0.8452 Intermediate Similarity NPC34012
0.8452 Intermediate Similarity NPC473755
0.8452 Intermediate Similarity NPC475513
0.8447 Intermediate Similarity NPC5115
0.8447 Intermediate Similarity NPC472549
0.8443 Intermediate Similarity NPC40138
0.8442 Intermediate Similarity NPC97667
0.8442 Intermediate Similarity NPC473081
0.8442 Intermediate Similarity NPC211137
0.8442 Intermediate Similarity NPC100913
0.8442 Intermediate Similarity NPC476094
0.8442 Intermediate Similarity NPC4341
0.8442 Intermediate Similarity NPC472547
0.8442 Intermediate Similarity NPC200592
0.8442 Intermediate Similarity NPC275592
0.8442 Intermediate Similarity NPC90614
0.8442 Intermediate Similarity NPC473613
0.8442 Intermediate Similarity NPC43241
0.8442 Intermediate Similarity NPC473112
0.8442 Intermediate Similarity NPC473758
0.8442 Intermediate Similarity NPC473085
0.8442 Intermediate Similarity NPC48017
0.8442 Intermediate Similarity NPC184747
0.8442 Intermediate Similarity NPC147880
0.8442 Intermediate Similarity NPC171207
0.8442 Intermediate Similarity NPC473060
0.8442 Intermediate Similarity NPC473109
0.8428 Intermediate Similarity NPC475417
0.8428 Intermediate Similarity NPC475561
0.8428 Intermediate Similarity NPC31829
0.8418 Intermediate Similarity NPC327031
0.8418 Intermediate Similarity NPC473760
0.8415 Intermediate Similarity NPC476077
0.8412 Intermediate Similarity NPC477617
0.8408 Intermediate Similarity NPC478264
0.8405 Intermediate Similarity NPC477736
0.8397 Intermediate Similarity NPC139067
0.8397 Intermediate Similarity NPC246480
0.8397 Intermediate Similarity NPC473673
0.8397 Intermediate Similarity NPC147217
0.8397 Intermediate Similarity NPC270498
0.8397 Intermediate Similarity NPC177340
0.8397 Intermediate Similarity NPC475429
0.8397 Intermediate Similarity NPC191082
0.8385 Intermediate Similarity NPC133430
0.8385 Intermediate Similarity NPC469477
0.8377 Intermediate Similarity NPC214550
0.8377 Intermediate Similarity NPC210591
0.8377 Intermediate Similarity NPC475652
0.8375 Intermediate Similarity NPC298072
0.8375 Intermediate Similarity NPC62792
0.8354 Intermediate Similarity NPC209592
0.8354 Intermediate Similarity NPC48599
0.8352 Intermediate Similarity NPC189704
0.8344 Intermediate Similarity NPC34943
0.8344 Intermediate Similarity NPC477735
0.8344 Intermediate Similarity NPC67777
0.8344 Intermediate Similarity NPC51314
0.8333 Intermediate Similarity NPC132599
0.8333 Intermediate Similarity NPC228204
0.8333 Intermediate Similarity NPC26033
0.8333 Intermediate Similarity NPC473632
0.8333 Intermediate Similarity NPC473611
0.8333 Intermediate Similarity NPC469730
0.8333 Intermediate Similarity NPC471176
0.8313 Intermediate Similarity NPC66193
0.8312 Intermediate Similarity NPC39549
0.8312 Intermediate Similarity NPC183122

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475567 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8235 Intermediate Similarity NPD7799 Discontinued
0.7977 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.795 Intermediate Similarity NPD7236 Approved
0.7818 Intermediate Similarity NPD7239 Suspended
0.7542 Intermediate Similarity NPD7685 Pre-registration
0.7542 Intermediate Similarity NPD8368 Discontinued
0.7514 Intermediate Similarity NPD8407 Phase 2
0.7459 Intermediate Similarity NPD8312 Approved
0.7459 Intermediate Similarity NPD8313 Approved
0.7405 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7399 Intermediate Similarity NPD7058 Phase 2
0.7399 Intermediate Similarity NPD7057 Phase 3
0.7384 Intermediate Similarity NPD8455 Phase 2
0.7377 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7366 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD8435 Approved
0.7351 Intermediate Similarity NPD8361 Approved
0.7351 Intermediate Similarity NPD8360 Approved
0.7277 Intermediate Similarity NPD8486 Clinical (unspecified phase)
0.7243 Intermediate Similarity NPD8434 Phase 2
0.7243 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD8127 Discontinued
0.7222 Intermediate Similarity NPD7228 Approved
0.7176 Intermediate Similarity NPD6273 Approved
0.7158 Intermediate Similarity NPD7240 Approved
0.7128 Intermediate Similarity NPD8320 Phase 1
0.7128 Intermediate Similarity NPD8319 Approved
0.712 Intermediate Similarity NPD8485 Approved
0.7107 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD7700 Phase 2
0.7083 Intermediate Similarity NPD7699 Phase 2
0.7077 Intermediate Similarity NPD7497 Discontinued
0.7059 Intermediate Similarity NPD8150 Discontinued
0.7052 Intermediate Similarity NPD7458 Discontinued
0.7032 Intermediate Similarity NPD8379 Approved
0.7032 Intermediate Similarity NPD8296 Approved
0.7032 Intermediate Similarity NPD8378 Approved
0.7032 Intermediate Similarity NPD8033 Approved
0.7032 Intermediate Similarity NPD8380 Approved
0.7032 Intermediate Similarity NPD8335 Approved
0.7006 Intermediate Similarity NPD7266 Discontinued
0.6994 Remote Similarity NPD7961 Discontinued
0.6984 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6982 Remote Similarity NPD8166 Discontinued
0.6968 Remote Similarity NPD8377 Approved
0.6968 Remote Similarity NPD7741 Discontinued
0.6968 Remote Similarity NPD8294 Approved
0.6957 Remote Similarity NPD7074 Phase 3
0.6951 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6932 Remote Similarity NPD37 Approved
0.6927 Remote Similarity NPD6535 Approved
0.6927 Remote Similarity NPD6534 Approved
0.6923 Remote Similarity NPD7503 Approved
0.691 Remote Similarity NPD4965 Approved
0.691 Remote Similarity NPD4967 Phase 2
0.691 Remote Similarity NPD4966 Approved
0.6904 Remote Similarity NPD7435 Discontinued
0.6903 Remote Similarity NPD7516 Approved
0.6902 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6879 Remote Similarity NPD5126 Approved
0.6879 Remote Similarity NPD5125 Phase 3
0.6871 Remote Similarity NPD7008 Discontinued
0.6865 Remote Similarity NPD7472 Approved
0.6855 Remote Similarity NPD7507 Approved
0.6851 Remote Similarity NPD7199 Phase 2
0.6845 Remote Similarity NPD7808 Phase 3
0.6839 Remote Similarity NPD7328 Approved
0.6839 Remote Similarity NPD7327 Approved
0.6835 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6833 Remote Similarity NPD6234 Discontinued
0.6832 Remote Similarity NPD7319 Approved
0.6821 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6818 Remote Similarity NPD7696 Phase 3
0.6818 Remote Similarity NPD7698 Approved
0.6818 Remote Similarity NPD7697 Approved
0.6818 Remote Similarity NPD7028 Phase 2
0.6816 Remote Similarity NPD8151 Discontinued
0.6811 Remote Similarity NPD5844 Phase 1
0.6811 Remote Similarity NPD7054 Approved
0.6798 Remote Similarity NPD5761 Phase 2
0.6798 Remote Similarity NPD5760 Phase 2
0.6797 Remote Similarity NPD8133 Approved
0.6791 Remote Similarity NPD6559 Discontinued
0.6791 Remote Similarity NPD7251 Discontinued
0.6784 Remote Similarity NPD4628 Phase 3
0.6782 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6782 Remote Similarity NPD7874 Approved
0.6778 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6768 Remote Similarity NPD6823 Phase 2
0.6766 Remote Similarity NPD7701 Phase 2
0.6751 Remote Similarity NPD6778 Approved
0.6751 Remote Similarity NPD6776 Approved
0.6751 Remote Similarity NPD6781 Approved
0.6751 Remote Similarity NPD6780 Approved
0.6751 Remote Similarity NPD6779 Approved
0.6751 Remote Similarity NPD6782 Approved
0.6751 Remote Similarity NPD6777 Approved
0.6749 Remote Similarity NPD7783 Phase 2
0.6749 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6738 Remote Similarity NPD6797 Phase 2
0.6738 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6702 Remote Similarity NPD6764 Approved
0.6702 Remote Similarity NPD6765 Approved
0.67 Remote Similarity NPD7870 Phase 2
0.67 Remote Similarity NPD7871 Phase 2
0.6688 Remote Similarity NPD6858 Approved
0.6688 Remote Similarity NPD7094 Approved
0.6685 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7801 Approved
0.6647 Remote Similarity NPD6190 Approved
0.6634 Remote Similarity NPD8462 Phase 1
0.663 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6629 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6615 Remote Similarity NPD6213 Phase 3
0.6615 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6615 Remote Similarity NPD6212 Phase 3
0.6611 Remote Similarity NPD7819 Suspended
0.6608 Remote Similarity NPD7702 Clinical (unspecified phase)
0.6603 Remote Similarity NPD2629 Approved
0.659 Remote Similarity NPD7003 Approved
0.6587 Remote Similarity NPD6663 Approved
0.6582 Remote Similarity NPD7610 Discontinued
0.6579 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6578 Remote Similarity NPD3818 Discontinued
0.6578 Remote Similarity NPD3751 Discontinued
0.6567 Remote Similarity NPD7680 Approved
0.6562 Remote Similarity NPD6785 Approved
0.6562 Remote Similarity NPD6784 Approved
0.6561 Remote Similarity NPD4198 Discontinued
0.6554 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6545 Remote Similarity NPD5736 Approved
0.6541 Remote Similarity NPD3787 Discontinued
0.6536 Remote Similarity NPD4380 Phase 2
0.6533 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6529 Remote Similarity NPD7097 Phase 1
0.6527 Remote Similarity NPD3764 Approved
0.6519 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6512 Remote Similarity NPD5762 Approved
0.6512 Remote Similarity NPD5763 Approved
0.6507 Remote Similarity NPD8404 Phase 2
0.6503 Remote Similarity NPD7075 Discontinued
0.65 Remote Similarity NPD8515 Approved
0.65 Remote Similarity NPD8517 Approved
0.65 Remote Similarity NPD8516 Approved
0.6497 Remote Similarity NPD5951 Approved
0.6494 Remote Similarity NPD6398 Clinical (unspecified phase)
0.648 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6477 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6471 Remote Similarity NPD6166 Phase 2
0.6471 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6471 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6463 Remote Similarity NPD7736 Approved
0.6462 Remote Similarity NPD8155 Clinical (unspecified phase)
0.646 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6448 Remote Similarity NPD7768 Phase 2
0.6437 Remote Similarity NPD6674 Discontinued
0.6436 Remote Similarity NPD7473 Discontinued
0.6432 Remote Similarity NPD5494 Approved
0.6422 Remote Similarity NPD7999 Approved
0.6422 Remote Similarity NPD7211 Clinical (unspecified phase)
0.642 Remote Similarity NPD8328 Phase 3
0.6416 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6416 Remote Similarity NPD6004 Phase 3
0.6416 Remote Similarity NPD6005 Phase 3
0.6416 Remote Similarity NPD6002 Phase 3
0.6416 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6405 Remote Similarity NPD6685 Approved
0.6398 Remote Similarity NPD8513 Phase 3
0.6398 Remote Similarity NPD6959 Discontinued
0.6393 Remote Similarity NPD5402 Approved
0.6393 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6389 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6383 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6364 Remote Similarity NPD6232 Discontinued
0.6364 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6364 Remote Similarity NPD6686 Approved
0.6358 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6354 Remote Similarity NPD6599 Discontinued
0.6353 Remote Similarity NPD4140 Approved
0.6346 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6335 Remote Similarity NPD7009 Phase 2
0.6333 Remote Similarity NPD7930 Approved
0.6325 Remote Similarity NPD3094 Phase 2
0.6323 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6319 Remote Similarity NPD7411 Suspended
0.6316 Remote Similarity NPD6355 Discontinued
0.6307 Remote Similarity NPD3750 Approved
0.6299 Remote Similarity NPD6412 Phase 2
0.6296 Remote Similarity NPD7997 Clinical (unspecified phase)
0.6294 Remote Similarity NPD7715 Approved
0.6294 Remote Similarity NPD7714 Approved
0.629 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6284 Remote Similarity NPD6801 Discontinued
0.6279 Remote Similarity NPD6653 Approved
0.6278 Remote Similarity NPD5403 Approved
0.6264 Remote Similarity NPD5404 Approved
0.6264 Remote Similarity NPD5405 Approved
0.6264 Remote Similarity NPD5406 Approved
0.6264 Remote Similarity NPD5408 Approved
0.6257 Remote Similarity NPD5401 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data